Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

0.0%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Mimbari	7/5/2013 2:07:57 PM
	Read Replies (1) of 13111

The truth about peer reviewed publications is that in general they are untruthful. Amgen, Bayer, and Merck have concluded that for the most part they contain false and unrepeatable claims 89% of the time. How can this be? 1.) Under pressure to be published and to save their jobs it would seem scientists are fabricating claims. 2.) It would also seem that the peer review process relies on lazy, incompetent or corruptible peers. Under this revelation why would anyone waste their time and energy to submitting to the peer reviewed process? It is obvious that big pharma doesn't believe in it. So who does? People that are involved in writing peer reviews. So who does big pharma trust? Independent labs such as Moffitt and MD Anderson. Out with the old and in with the new. At least in the case of FDA approval and big pharma interests.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next